Previous 10 | Next 10 |
Penske Automotive Group Inc. (PAG) is expected to report $3.66 for Q4 2023 Copa Holdings S.A. Class A (CPA) is expected to report $3.9 for Q4 2023 Wynn Resorts Limited (WYNN) is expected to report $1.12 for Q4 2023 U-Haul Holding Co Com (UHAL) is expected to report $0.82 for Q3 2024 ...
Toronto, Ontario--(Newsfile Corp. - February 6, 2024) - STLLR Gold Inc. (formerly Moneta Gold Inc.) (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) (" STLLR ") and Nighthawk Gold Corp. (" Nighthawk ") (TSX: NHK) are pleased to announce the completion of their previously announced at-market merger (the "...
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that several lawsuits were filed by consumers with an account at 23andMe Holding Co. (NASDAQ: ME) in connection with the massive data breach at 23andMe Holding Co. in the end of 2023. Consumers who have...
2024-01-31 08:19:34 ET More on 23andMe 23andMe Holding Co. (ME) Q2 2024 Earnings Call Transcript 23andMe facing mounting litigation over hacking incident Hackers accessed personal data for 6.9M 23andMe users: report Seeking Alpha’s Quant Rating on 23an...
2024-01-31 07:57:44 ET 23andMe (NASDAQ: ME) stock price has had a spectacular collapse and is at risk of being booted from NASDAQ. After peaking at over $16 in 2021, the stock has dropped to just 71 cents, making it one of the worst-performing companies. Its market cap has plummeted fro...
23ME-01473 (‘1473) seeks to treat cancer by restoring anti-tumor immunity through NK and T cells ‘1473 has dual mechanisms of blocking the immunosuppressive effects of soluble ULBP6, and inducing Fc receptor-mediated killing of ULBP6-expressing cancer cells through enhan...
SUNNYVALE, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic health and biopharmaceutical company, announced a month-long initiative to amplify Ava DuVernay’s new film ORIGIN and the film’s groundbreaking Seat16 ...
Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - Nighthawk Gold Corp. (" Nighthawk ") (TSX: NHK) and Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) (" Moneta ") are pleased to announce that on January 30, 2024, the Ontario Superior Court of Justice (Commercial List) granted a fi...
Toronto, Ontario--(Newsfile Corp. - January 29, 2024) - Nighthawk Gold Corp. (" Nighthawk ") (TSX: NHK) and Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) (" Moneta ") are pleased to announce that all applicable resolutions in connection with the proposed plan of arrangement involving ...
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Hea...
SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by 23andMe Research) for 23andMe+ Premium members, informing them if they are at h...
2024-06-04 12:48:12 ET Genetic database builder 23andMe (NASDAQ: ME) stock slid 10% through 12:05 p.m. ET Tuesday. Curiously, though, the news that 23andMe reported today seemed generally of the "good" variety. The company announced a collaboration with the nonprofit Colorectal ...